However, atorvastatin treatment has no impact on troponin release, NT-proBNP levels or post-operative right atrial refractoriness and, by implication, myocardial injury, LV function, and the development of a functional substrate favouring post-operative AF. The gene discussed is NPPB; the disease is atrial fibrillation.